Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System.

Abstract:

:Allogeneic stem cell transplantation with umbilical cord blood (UCB) cells is limited by the cell dose a single unit provides recipients. Ex vivo expansion is one strategy to increase the number of cells available for transplantation. Aastrom Biosciences developed an automated continuous perfusion culture device for expansion of hematopoietic stem cells (HSCs). Cells are expanded in media supplemented with fetal bovine serum, horse serum, PIXY321, flt-3 ligand, and erythropoietin. We performed a phase 1 trial augmenting conventional UCB transplants with ex vivo-expanded cells. The 28 patients were enrolled on the trial between October 8, 1997 and September 30, 1998. UCB cells were expanded in the device, then administered as a boost to the conventional graft on posttransplantation day 12. While expansion of total cells and colony-forming units (CFUs) occurred in all cases, the magnitude of expansion varied considerably. The median fold increase was 2.4 (range, 1.0-8.5) in nucleated cells, 82 (range, 4.6-266.4) in CFU granulocyte-macrophages, and 0.5 (range, 0.09-2.45) in CD34+ lineage negative (lin-) cells. CD3+ cells did not expand under these conditions. Clinical-scale ex vivo expansion of UCB is feasible, and the administration of ex vivo-expanded cells is well tolerated. Augmentation of UCB transplants with ex vivo-expanded cells did not alter the time to myeloid, erythroid, or platelet engraftment in 21 evaluable patients. Recipients of ex vivo-expanded cells continue to have durable engraftment with a median follow-up of 47 months (range, 41-51 months). A randomized phase 2 study will determine whether augmenting UCB transplants with ex vivo-expanded UCB cells is beneficial.

journal_name

Blood

journal_title

Blood

authors

Jaroscak J,Goltry K,Smith A,Waters-Pick B,Martin PL,Driscoll TA,Howrey R,Chao N,Douville J,Burhop S,Fu P,Kurtzberg J

doi

10.1182/blood-2001-12-0290

subject

Has Abstract

pub_date

2003-06-15 00:00:00

pages

5061-7

issue

12

eissn

0006-4971

issn

1528-0020

pii

2001-12-0290

journal_volume

101

pub_type

临床试验,杂志文章

相关文献

BLOOD文献大全
  • An early decrease in Notch activation is required for human TCR-alphabeta lineage differentiation at the expense of TCR-gammadelta T cells.

    abstract::Although well characterized in the mouse, the role of Notch signaling in the human T-cell receptor alphabeta (TCR-alphabeta) versus TCR-gammadelta lineage decision is still unclear. Although it is clear in the mouse that TCR-gammadelta development is less Notch dependent compared with TCR-alphabeta differentiation, re...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-06-164871

    authors: Van de Walle I,De Smet G,De Smedt M,Vandekerckhove B,Leclercq G,Plum J,Taghon T

    更新日期:2009-03-26 00:00:00

  • Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone.

    abstract::Relapse following remission induction chemotherapy remains a barrier to survival in approximately 20% of children suffering from acute lymphoblastic leukemia (ALL). To investigate the mechanism of relapse, 27 matched diagnosis and relapse ALL samples were analyzed for clonal populations using polymerase chain reaction...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-01-067785

    authors: Choi S,Henderson MJ,Kwan E,Beesley AH,Sutton R,Bahar AY,Giles J,Venn NC,Pozza LD,Baker DL,Marshall GM,Kees UR,Haber M,Norris MD

    更新日期:2007-07-15 00:00:00

  • BCR-ABL antisense oligodeoxynucleotide in vitro purging and autologous bone marrow transplantation for patients with chronic myelogenous leukemia in advanced phase.

    abstract::BCR-ABL antisense oligodeoxynucleotides (ODN) have provided evidence of antileukemia effect when tested in vitro against Philadelphia-positive (Ph-pos) cells and in vivo when injected into leukemic mice. On the basis of the results obtained in vitro at diagnosis, eight patients with chronic myelogenous leukemia (CML) ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: de Fabritiis P,Petti MC,Montefusco E,De Propris MS,Sala R,Bellucci R,Mancini M,Lisci A,Bonetto F,Geiser T,Calabretta B,Mandelli F

    更新日期:1998-05-01 00:00:00

  • Relation of autonomous and interleukin-2-responsive growth of leukemic cells to survival in adult T-cell leukemia.

    abstract::We examined autonomous and interleukin-2 (IL-2)-responsive growth activities of leukemic cells derived from peripheral blood, as well as several clinical manifestations, including serum lactate dehydrogenase (LDH) level, of 35 patients with adult T-cell leukemia (ATL) to determine whether these properties were related...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Arima N,Hidaka S,Fujiwara H,Matsushita K,Ohtsubo H,Arimura K,Kukita T,Fukumori J,Tanaka H

    更新日期:1996-04-01 00:00:00

  • Fli1, Elf1, and Ets1 regulate the proximal promoter of the LMO2 gene in endothelial cells.

    abstract::Transcriptional control has been identified as a key mechanism regulating the formation and subsequent behavior of hematopoietic stem cells. We have used a comparative genomics approach to identify transcriptional regulatory elements of the LMO2 gene, a transcriptional cofactor originally identified through its involv...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-12-4755

    authors: Landry JR,Kinston S,Knezevic K,Donaldson IJ,Green AR,Göttgens B

    更新日期:2005-10-15 00:00:00

  • Intensive leukapheresis as initial therapy for chronic granulocytic leukemia.

    abstract::Intensive leukapheresis has been used as the initial treatment of chronic granulocytic leukemia (CGL) in six patients. The number of leukaphereses ranged from 3 in 7 days to 13 in 39 days (mean, 8 in 22 days). The procedures were well tolerated, and in all patients there was improvement in hematologic values, in most ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lowenthal RM,Buskard NA,Goldman JM,Spiers AS,Bergier N,Graubner M,Galton DA

    更新日期:1975-12-01 00:00:00

  • Vitamin D receptor-mediated skewed differentiation of macrophages initiates myelofibrosis and subsequent osteosclerosis.

    abstract::Myelofibrosis in myeloproliferative neoplasms (MPNs) with mutations such as JAK2V617F is an unfavorable sign for uncontrollable disease progression in the clinic and is complicated with osteosclerosis whose pathogenesis is largely unknown. Because several studies have revealed that macrophages are an indispensable sup...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-09-876615

    authors: Wakahashi K,Minagawa K,Kawano Y,Kawano H,Suzuki T,Ishii S,Sada A,Asada N,Sato M,Kato S,Shide K,Shimoda K,Matsui T,Katayama Y

    更新日期:2019-04-11 00:00:00

  • Both TMEM16F-dependent and TMEM16F-independent pathways contribute to phosphatidylserine exposure in platelet apoptosis and platelet activation.

    abstract::Scott syndrome, a bleeding disorder caused by defective phospholipid scrambling, has been associated with mutations in the TMEM16F gene. The role of TMEM16F in apoptosis- or agonist-induced phosphatidylserine (PS) exposure was studied in platelets from a Scott syndrome patient and control subjects. Whereas stimulation...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-09-454314

    authors: van Kruchten R,Mattheij NJ,Saunders C,Feijge MA,Swieringa F,Wolfs JL,Collins PW,Heemskerk JW,Bevers EM

    更新日期:2013-03-07 00:00:00

  • Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia.

    abstract::We made a disease-specific comparison of unrelated cord blood (CB) recipients and human leukocyte antigen allele-matched unrelated bone marrow (BM) recipients among 484 patients with acute myeloid leukemia (AML; 173 CB and 311 BM) and 336 patients with acute lymphoblastic leukemia (ALL; 114 CB and 222 BM) who received...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2008-03-147041

    authors: Atsuta Y,Suzuki R,Nagamura-Inoue T,Taniguchi S,Takahashi S,Kai S,Sakamaki H,Kouzai Y,Kasai M,Fukuda T,Azuma H,Takanashi M,Okamoto S,Tsuchida M,Kawa K,Morishima Y,Kodera Y,Kato S,Japan Cord Blood Bank Network.

    更新日期:2009-02-19 00:00:00

  • Combination therapy for radiation-induced bone marrow aplasia in nonhuman primates using synthokine SC-55494 and recombinant human granulocyte colony-stimulating factor.

    abstract::Combination cytokine therapy continues to be evaluated in an effort to stimulate multilineage hematopoietic reconstitution after bone marrow myelosuppression. This study evaluated the efficacy of combination therapy with the synthetic interleukin-3 receptor agonist, Synthokine-SC55494, and recombinant methionyl human ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: MacVittie TJ,Farese AM,Herodin F,Grab LB,Baum CM,McKearn JP

    更新日期:1996-05-15 00:00:00

  • Photochemical inactivation of cell-associated human immunodeficiency virus in platelet concentrates.

    abstract::Photochemical decontamination (PCD) of platelet concentrates, with adequate preservation of platelet function, has been shown using 8-methoxypsoralen (8-MOP) and long wavelength UV light (UVA). To further evaluate this technique, models for the inactivation of pathogenic human cell-associated viruses and integrated pr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lin L,Londe H,Hanson CV,Wiesehahn G,Isaacs S,Cimino G,Corash L

    更新日期:1993-07-01 00:00:00

  • Administration of recombinant human interleukin-7 alters the frequency and number of myeloid progenitor cells in the bone marrow and spleen of mice.

    abstract::The administration of greater than or equal to 5 micrograms interleukin-7 (IL-7) twice a day to mice for 4 to 7 days increased by twofold to fivefold the total number of splenic and peripheral blood leukocytes, but did not appreciably increase bone marrow (BM) cellularity. This regimen of IL-7 administration also resu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Damia G,Komschlies KL,Faltynek CR,Ruscetti FW,Wiltrout RH

    更新日期:1992-03-01 00:00:00

  • Mapping of genes that control the antibody response to human factor IX in mice.

    abstract::We tested the hypothesis that the antibody response to human factor IX in mice is controlled by genetic factors, especially histocompatibility antigens. Seven inbred mouse strains were immunized against human factor IX by adenoviral gene transfer or serial injections of human factor IX protein. A/J mice had the highes...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-03-1126

    authors: Lozier JN,Tayebi N,Zhang P

    更新日期:2005-02-01 00:00:00

  • Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells.

    abstract::Recent studies suggest plasmacytoid predendritic cells (pDCs) and myeloid dendritic cells (mDCs) have the functional plasticity to produce similar amounts of type 1 interferons (IFNs) and interleukin-12 (IL-12), challenging the concept and existence of DC subsets with distinct function. In this study, we demonstrate t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-07-2709

    authors: Ito T,Kanzler H,Duramad O,Cao W,Liu YJ

    更新日期:2006-03-15 00:00:00

  • Mycobacterium avium-intracellulare induces interleukin-6 from human monocytes and large granular lymphocytes.

    abstract::Mycobacterium avium-intracellulare (MAI) is an opportunistic pathogen commonly found in acquired immunodeficiency syndrome patients, whose immune systems are severely compromised. However, normal responses to this bacterium are apparently sufficient to prevent disseminated infection because disease is rarely found unl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Blanchard DK,Michelini-Norris MB,Pearson CA,Freitag CS,Djeu JY

    更新日期:1991-05-15 00:00:00

  • Acidic isoferritins and E-type prostaglandins in sources of colony stimulatory factors mask detection of cycling granulocyte-macrophage progenitor cells.

    abstract::The effect of granulocyte-macrophage colony stimulatory factors (GM-CSF), acidic isoferritins, and E-type prostaglandins on the detection of the cycle status of human granulocyte-macrophage progenitor cells (CFU-GM) was investigated. Bone marrow cells were pulse-treated with control medium or high specific activity tr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Broxmeyer HE

    更新日期:1982-10-01 00:00:00

  • HbF reactivation in sibling BFU-E colonies: synergistic interaction of kit ligand with low-dose dexamethasone.

    abstract::Mechanisms underlying fetal hemoglobin (HbF) reactivation in stress erythropoiesis have not been fully elucidated. We suggested that a key role is played by kit ligand (KL). Because glucocorticoids (GCs) mediate stress erythropoiesis, we explored their capacity to potentiate the stimulatory effect of KL on HbF reactiv...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-05-1477

    authors: Gabbianelli M,Testa U,Massa A,Morsilli O,Saulle E,Sposi NM,Petrucci E,Mariani G,Peschle C

    更新日期:2003-04-01 00:00:00

  • p53 abnormalities in splenic lymphoma with villous lymphocytes.

    abstract::The incidence and role of p53 abnormalities have not been reported in splenic lymphoma with villous lymphocytes (SLVL), the leukemic counterpart of splenic marginal zone lymphoma. Because p53 abnormalities correlate with progressive and refractory disease in cancer and isochromosome 17q has been described in SLVL, a l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.11.3552

    authors: Gruszka-Westwood AM,Hamoudi RA,Matutes E,Tuset E,Catovsky D

    更新日期:2001-06-01 00:00:00

  • Prolonged expression of c-fos suppresses cell cycle entry of dormant hematopoietic stem cells.

    abstract::The proto-oncogene c-fos was transiently upregulated in primitive hematopoietic stem (Lin-Sca-1(+)) cells stimulated with stem cell factor, interleukin-3 (IL-3), and IL-6. To investigate a role of the c-fos in hematopoietic stem cells, we used bone marrow (BM) cells from transgenic mice carrying the c-fos gene under t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Okada S,Fukuda T,Inada K,Tokuhisa T

    更新日期:1999-02-01 00:00:00

  • Interleukin-10 suppresses IP-10 gene transcription by inhibiting the production of class I interferon.

    abstract::Interleukin-10 (IL-10) selectively inhibited lipopolysaccharide (LPS)-induced chemoattractant cytokine gene expression: levels of IP-10 mRNA were markedly suppressed in IL-10-treated mouse peritoneal macrophages, whereas the expression of the RANTES mRNA was only modestly reduced. IL-10 inhibited IP-10 mRNA accumulati...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tebo JM,Kim HS,Gao J,Armstrong DA,Hamilton TA

    更新日期:1998-12-15 00:00:00

  • Gene transfer into normal human hematopoietic cells using in vitro and in vivo assays.

    abstract::The ability to transfer new genetic material into human hematopoietic cells provides the foundation for characterizing the organization and developmental program of human hematopoietic stem cells. It also provides a valuable model in which to test gene transfer and long-term expression in human hematopoietic cells as ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dick JE,Kamel-Reid S,Murdoch B,Doedens M

    更新日期:1991-08-01 00:00:00

  • Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor.

    abstract::Acute myeloid leukemia (AML) is an aggressive malignancy with a relapse rate approaching 50%, despite aggressive chemotherapy. New therapies for AML are targeted at signal transduction pathways known to support blast survival, such as the Stat3 pathway. Aberrant activation of Stat3 has been demonstrated in many differ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-04-280123

    authors: Redell MS,Ruiz MJ,Alonzo TA,Gerbing RB,Tweardy DJ

    更新日期:2011-05-26 00:00:00

  • IgE alone stimulates mast cell adhesion to fibronectin via pathways similar to those used by IgE + antigen but distinct from those used by Steel factor.

    abstract::We recently demonstrated that immunoglobulin E (IgE), in the absence of cross-linking agents, activates signaling pathways in healthy murine bone marrow-derived mast cells (BMMCs) and that this activation enhances BMMC survival, at least in part, via secretion of autocrine-acting cytokines. We report herein that IgE a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-10-3176

    authors: Lam V,Kalesnikoff J,Lee CW,Hernandez-Hansen V,Wilson BS,Oliver JM,Krystal G

    更新日期:2003-08-15 00:00:00

  • Origins of "late" relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes.

    abstract::Approximately 20% of childhood B-precursor acute lymphoblastic leukemia (ALL) has a TEL-AML1 fusion gene, often in association with deletions of the nonrearranged TEL allele. TEL-AML1 gene fusion appears to be an initiating event and usually occurs before birth, in utero. This subgroup of ALL generally presents with l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.3.558

    authors: Ford AM,Fasching K,Panzer-Grümayer ER,Koenig M,Haas OA,Greaves MF

    更新日期:2001-08-01 00:00:00

  • Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor.

    abstract::Human natural killer (NK) cell development is a step-by-step process characterized by phenotypically identified stages. CD161 is a marker informative of the NK cell lineage commitment, whereas CD56, CD117, and CD94/NKG2A contribute to define discrete differentiation stages. In cells undergoing in vitro differentiation...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-09-379693

    authors: Montaldo E,Vitale C,Cottalasso F,Conte R,Glatzer T,Ambrosini P,Moretta L,Mingari MC

    更新日期:2012-04-26 00:00:00

  • Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).

    abstract::The Children's Cancer Group (CCG) and the Pediatric Oncology Group (POG) joined to form the Children's Oncology Group (COG) in 2000. This merger allowed analysis of clinical, biologic, and early response data predictive of event-free survival (EFS) in acute lymphoblastic leukemia (ALL) to develop a new classification ...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2006-01-024729

    authors: Schultz KR,Pullen DJ,Sather HN,Shuster JJ,Devidas M,Borowitz MJ,Carroll AJ,Heerema NA,Rubnitz JE,Loh ML,Raetz EA,Winick NJ,Hunger SP,Carroll WL,Gaynon PS,Camitta BM

    更新日期:2007-02-01 00:00:00

  • Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation.

    abstract::Signal transducer and activator of transcription 3 (STAT3) is considered a negative regulator of inflammation, as inhibition of STAT3 signaling enhances antitumor immunity. However, STAT3 activation is a key oncogenic pathway in natural killer (NK)-lineage large granular lymphomas, and we recently reported enhanced pr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-05-499707

    authors: Zhu S,Phatarpekar PV,Denman CJ,Senyukov VV,Somanchi SS,Nguyen-Jackson HT,Mace EM,Freeman AF,Watowich SS,Orange JS,Holland SM,Lee DA

    更新日期:2014-07-17 00:00:00

  • Single-strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for glycoprotein IIIa.

    abstract::Glanzmann thrombasthenia (GT) is the most common inherited disorder of platelets. Most of the molecular defects previously identified in GT have been caused by point (or other small) mutations in the genes for glycoprotein (GP) IIb or GPIIIa. We have used single-strand conformation polymorphism (SSCP) analysis to rapi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jin Y,Dietz HC,Nurden A,Bray PF

    更新日期:1993-10-15 00:00:00

  • Induction of megakaryocytopoiesis and thrombocytopoiesis by JTZ-132, a novel small molecule with thrombopoietin mimetic activities.

    abstract::We report in this paper that a novel small molecule, JTZ-132, induced growth and differentiation of megakaryocytic progenitor cells and improved thrombocytopenia in myelosuppressed mice. JTZ-132 stimulated proliferation of UT-7/TPO cells, a cell line highly sensitive to thrombopoietin (TPO), and exhibited full efficac...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-10-3623

    authors: Inagaki K,Oda T,Naka Y,Shinkai H,Komatsu N,Iwamura H

    更新日期:2004-07-01 00:00:00

  • Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation.

    abstract::To explore the use of stem/progenitor cells from peripheral blood (PB) for allogeneic transplantation, we have studied the mobilization of progenitor cells in normal donors by growth factors. Normal subjects were administered either granulocyte-macrophage colony-stimulating factor (GM-CSF) at 10 micrograms/kg/d, or G-...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lane TA,Law P,Maruyama M,Young D,Burgess J,Mullen M,Mealiffe M,Terstappen LW,Hardwick A,Moubayed M

    更新日期:1995-01-01 00:00:00